The Medicines Company to Announce Second-Quarter 2018 Financial Results on August 1

26 Jul 2018

PARSIPPANY, N.J.--(BUSINESS WIRE)--Jul. 26, 2018-- The Medicines Company (NASDAQ:MDCO) will host a conference call and audio webcast on Wednesday, August 1, 2018, at 8:30 a.m. EDT to discuss its second-quarter 2018 financial results and operational developments.

The conference call may be accessed by telephone as follows:

U.S./Canada: (877) 359-9508
International: (224) 357-2393
Conference ID: 5847059

A taped replay of the conference call will be available after the call concludes, and may be accessed by telephone as follows:

U.S./Canada: (855) 859-2056
International: (404) 537-3406
Conference ID: 5847059

A live audio webcast of the conference call may be accessed in the Investors section of The Medicines Company website. An archived webcast will be available after the call concludes.

About The Medicines Company

The Medicines Company is a biopharmaceutical company driven by an overriding purpose – to save lives, alleviate suffering and contribute to the economics of healthcare. The Company’s goal is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians, and providers in cardiovascular care. The Company is headquartered in Parsippany, New Jersey.

Source: The Medicines Company

Investor Relations
The Medicines Company
Krishna Gorti, M.D., (973) 290-6122
Vice President, Investor Relations
krishna.gorti@themedco.com